Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
24 hedge funds and large institutions have $1.1M invested in Vaccinex, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
0% more funds holding
Funds holding: 24 → 24 (0)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
65% less capital invested
Capital invested by funds: $3.12M → $1.1M (-$2.01M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$54.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$51.8K |
| 3 |
Millennium Management
New York
|
+$38.2K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$16.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$14.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$785K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$193K |
| 3 |
VRM
Vectors Research Management
New York
|
-$6K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$2.86K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$1.21K |
VCNX Hedge Fund Activity: Q1 2023 in Review
24 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q1 2023, worth a combined $1.1M — down 65% from $3.12M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new VCNX positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $54.4K. The largest seller was AIGH Capital Management, cutting an estimated $785K.
- 24 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $1.1M of Vaccinex, Inc. Common Stock stock for Q1 2023, down 65% quarter-over-quarter.
- 5 funds opened new Vaccinex, Inc. Common Stock positions in Q1 2023 and 3 closed out, a net change of +2 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q1 2023 was Virtu Financial, an estimated $54.4K added.
- The largest Vaccinex, Inc. Common Stock seller in Q1 2023 was AIGH Capital Management, an estimated $785K sold.
Based on aggregated 13F filings for Q1 2023.